FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jesus-Vicente de Julián-Ortiz

Research Profile

Occupations

Drug Design

Concepts & Ideas

Genes & Molecular Sequences

Molecular Structure

Procedures

Chemicals & Drugs

Living Beings

Mycobacterium kansasii

Co-author Network

Publications

TOP 3
Yovani Marrero-Ponce; Alfredo Meneses Marcel; Oscar M Rivera-Borroto; Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz; Alina Montero; José Antonio Escario; Alicia Gómez Barrio; David Montero Pereira; Juan José Nogal; Ricardo Grau; Francisco Torrens; Christian Vogel; Vicente J Arán
Bond-based linear indices in QSAR: computational discovery of novel anti-trichomonal compounds.
Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz; Emili Besalú
True prediction of lowest observed adverse effect levels.
Nassira Mahmoudi; Jesus-Vicente de Julián-Ortiz; Liliane Ciceron; Jorge Gálvez; Dominique Mazier; Martin Danis; Francis Derouin; Ramón García-Domenech
Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jesus-Vicente de Julián-Ortiz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Yovani Marrero-Ponce; Alfredo Meneses Marcel; Oscar M Rivera-Borroto; Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz; Alina Montero; José Antonio Escario; Alicia Gómez Barrio; David Montero Pereira; Juan José Nogal; Ricardo Grau; Francisco Torrens; Christian Vogel; Vicente J Arán
Bond-based linear indices in QSAR: computational discovery of novel anti-trichomonal compounds.
Journal of computer-aided molecular design 2008;22(8):523-40.
2006: Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz; Emili Besalú
True prediction of lowest observed adverse effect levels.
Molecular diversity 2006;10(2):159-68.
2006: Nassira Mahmoudi; Jesus-Vicente de Julián-Ortiz; Liliane Ciceron; Jorge Gálvez; Dominique Mazier; Martin Danis; Francis Derouin; Ramón García-Domenech
Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening.
The Journal of antimicrobial chemotherapy 2006;57(3):489-97.
2005: Remedios Guna; Carlos Muñoz; Victoria Domínguez; Angeles García-García; Jorge Gálvez; Jesus-Vicente de Julián-Ortiz; Rafael Borrás
In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
The Journal of antimicrobial chemotherapy 2005;55(6):950-3.
2005: Jesus-Vicente de Julián-Ortiz; Ramón García-Domenech; Jorge Gálvez; L Pogliani
Predictability and prediction of lowest observed adverse effect levels in a structurally heterogeneous set of chemicals.
SAR and QSAR in environmental research 2005;16(3):263-72.
2005: Angeles García-García; Jorge Gálvez; Jesus-Vicente de Julián-Ortiz; Ramón García-Domenech; Carlos Muñoz; Remedios Guna; Rafael Borrás
Search of chemical scaffolds for novel antituberculosis agents.
Journal of biomolecular screening 2005;10(3):206-14.
2004: Juan Luco; Jorge Gálvez; Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz
Structural invariants for the prediction of relative toxicities of polychloro dibenzo-p-dioxins and dibenzofurans.
Molecular diversity 2004;8(4):331-42.
2004: Angeles García-García; Jorge Gálvez; Jesus-Vicente de Julián-Ortiz; Ramón García-Domenech; Carlos Muñoz; Remedios Guna; Rafael Borrás
New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method.
The Journal of antimicrobial chemotherapy 2004;53(1):65-73.
2003: Emili Besalú; Robert Ponec; Jesus-Vicente de Julián-Ortiz
Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study.
Molecular diversity 2003;6(2):107-20.
2001: Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz; María J Duart; J M García-Torrecillas; Gerardo M Antón-Fos; Inmaculada Ríos-Santamarina; C de Gregorio Alapont; Jorge Gálvez
Search of a topological pattern to evaluate toxicity of heterogeneous compounds.
SAR and QSAR in environmental research 2001;12(1-2):237-54.
1999: Jesus-Vicente de Julián-Ortiz; Jorge Gálvez; C Muñoz-Collado; Ramón García-Domenech; C Gimeno-Cardona
Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds.
Journal of medicinal chemistry 1999;42(17):3308-14.
1998: Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz
Antimicrobial activity characterization in a heterogeneous group of compounds.
Journal of chemical information and computer sciences 1998;38(3):445-9.
1998: Jesus-Vicente de Julián-Ortiz; C de Gregorio Alapont; Inmaculada Ríos-Santamarina; R García-Doménech; Jorge Gálvez
Prediction of properties of chiral compounds by molecular topology.
Journal of molecular graphics & modelling 1998;16(1):14-8.
1997: Francisco J García-March; Ramón García-Domenech; Jorge Gálvez; Gerardo M Antón-Fos; Jesus-Vicente de Julián-Ortiz; R Giner-Pons; M C Recio-Iglesias
Pharmacological studies of 1-(p-chlorophenyl)propanol and 2-(1-hydroxy-3-butenyl)phenol: two new non-narcotic analgesics designed by molecular connectivity.
The Journal of pharmacy and pharmacology 1997;49(1):10-5.
1996: Jorge Gálvez; Ramón García-Domenech; C de Gregorio Alapont; Jesus-Vicente de Julián-Ortiz; L Popa
Pharmacological distribution diagrams: a tool for de novo drug design.
Journal of molecular graphics 1996;14(5):272-6.
1995: Jorge Gálvez; Ramón García-Domenech; Jesus-Vicente de Julián-Ortiz; R Soler
Topological approach to drug design.
Journal of chemical information and computer sciences 1995;35(2):272-84.